MODULATION OF AN ANIMAL MODEL OF HYPERTHYROIDISM
甲亢动物模型的调节
基本信息
- 批准号:6342525
- 负责人:
- 金额:$ 31.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-02-15 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:Graves disease T lymphocyte antibody specificity autoantibody disease /disorder model enzyme linked immunosorbent assay fibroblasts flow cytometry gender difference hormone receptor hyperthyroidism iodide peroxidase iodine laboratory mouse lymphocyte proliferation pathologic process protein structure thyrotropin
项目摘要
Graves' hyperthyroidism, a very common autoimmune disorder affecting
primarily women, is caused by TSH receptor (TSHR) autoantibodies that
mimic the action of TSH. Very recently, the first animal model has been
developed with the hallmarks of Graves' hyperthyroidism. We now propose
to use this "Chiba" model to investigate several critical issues in
Graves' disease, including exploration of approaches for immune
intervention. 1. Addressing critical issues in Graves' disease:- The
Chiba mouse model will be used to study the role of thyroid peroxidase
(TPO) antibodies (common in Graves' disease), TSHR intramolecular
cleavage, gender and iodide ingestion on development and course of
hyperthyroidism 2. TSHR Antibody characterization:- TSHR antibodies
arising in the Chiba mouse model will be characterized by approaches
used for human TSHR autoantibodies, including:- (i) functional assays
for TSH binding inhibition (TBI), thyroid stimulating immunoglobulin
(TSI) and antibodies that block the biological action of TSH (TSBAb),
(ii) epitopes and (iii) flow cytometry with intact cells to examine
binding of non-functional TSHR antibodies. 3. TPO antibody
characterization:- We will determine whether TPO antibodies in the Chiba
model resemble human autoantibodies in terms of their:- (i) affinities,
(ii) preferential recognition of native TPO and, (iii) preferential
interaction with epitopes in the immunodominant region recognized by
human TPO autoantibodies. 4. T Cell responses to TSHR antigen:- With
the Chiba model of Graves' disease, we will:- (i) study the role of T
cells in providing help in the generation of functional TSHR antibodies,
(ii) determine the cytokines secreted by TSHR-specific T cells and,
(iii) determine if the proliferative response of TSHR-specific T cell
clones will vary depending on the antigen presenting cell (macrophages,
B cells or syngeneic TSHR-expressing fibroblasts) 5. Intervention in
the immune response in the Chiba model:- The Chiba model now makes
feasible studies on the immunotherapy of hyperthyroidism in these
animals, a long road that may ultimately provide the basis for immune
intervention in human disease. We propose to examine the effect of
second signal blockade (anti-CD40L) as a means to:- (i) Prevent the
induction of disease and reverse the course of established disease and,
(ii) Target a specific antigen (TSHR), rather than employing blanket
suppression of the immune response.
格雷夫斯甲状腺机能亢进是一种非常常见的自身免疫性疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sandra M McLachlan其他文献
Sandra M McLachlan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sandra M McLachlan', 18)}}的其他基金
GENETIC SUSCEPTIBILITY TO GRAVES'-LIKE HYPERTHYROIDISM IN MICE
小鼠对格雷夫斯样甲状腺功能亢进症的遗传易感性
- 批准号:
8307012 - 财政年份:2010
- 资助金额:
$ 31.58万 - 项目类别:
GENETIC SUSCEPTIBILITY TO GRAVES'-LIKE HYPERTHYROIDISM IN MICE
小鼠对格雷夫斯样甲状腺功能亢进症的遗传易感性
- 批准号:
8712469 - 财政年份:2010
- 资助金额:
$ 31.58万 - 项目类别:
GENETIC SUSCEPTIBILITY TO GRAVES'-LIKE HYPERTHYROIDISM IN MICE
小鼠对格雷夫斯样甲状腺功能亢进症的遗传易感性
- 批准号:
7962365 - 财政年份:2010
- 资助金额:
$ 31.58万 - 项目类别:
GENETIC SUSCEPTIBILITY TO GRAVES'-LIKE HYPERTHYROIDISM IN MICE
小鼠对格雷夫斯样甲状腺功能亢进症的遗传易感性
- 批准号:
8100177 - 财政年份:2010
- 资助金额:
$ 31.58万 - 项目类别:
GENETIC SUSCEPTIBILITY TO GRAVES'-LIKE HYPERTHYROIDISM IN MICE
小鼠对格雷夫斯样甲状腺功能亢进症的遗传易感性
- 批准号:
8502473 - 财政年份:2010
- 资助金额:
$ 31.58万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 31.58万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 31.58万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 31.58万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 31.58万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




